unknown
Stage
1
Investors
About
AEYE Health provides FDA-cleared autonomous AI diagnostic screening solutions for diabetic retinopathy using portable and tabletop retinal imaging devices, enabling on-the-spot diagnosis without physician interpretation.
Explore AEYE Health's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.